PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection
2026-09-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Nuritas Appoints Former Unilever North America President Kees Kruythoff as Board Chair
2026-09-10T    Biotechnology   Health Care/Hospital 
/C O R R E C T I O N -- CordenPharma/
2026-09-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health
2026-09-09T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Yuyu Pharma CEO Robert Wonsang Yu Launches "Robert's YUniverse" Podcast
2026-09-09T    Biotechnology   Medical/Pharmaceuticals 
First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
2026-09-09T    Banking/Financial Service   Biotechnology 
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [22⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
2026-09-09T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Daesang Targets Global Pharmaceutical Amino Acid Market, Building on 70 Years of Fermentation Technology
2026-09-09T    Biotechnology   Food/Beverages   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.